Claim Missing Document
Check
Articles

Found 2 Documents
Search

PENGARUH SUPLEMENTASI VITAMIN D TERHADAP KADAR HDAC2 PADA PASIEN PPOK STABIL Adyan Donastin; Danny Irawan; Effendy; Rifky Dwi Aditya Iryawan; Nuzlan Nuari; Betta Mega Oktaviana; Devy Yahya; Akbar Reza Muhammad
Klinikal Sains : Jurnal Analis Kesehatan Vol. 14 No. 1 (2026): Juni
Publisher : LPPM Universitas Abdurrab

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36341/klinikal_sains.v14i1.7750

Abstract

Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of global mortality, characterised by persistent lung inflammation partly associated with reduced levels of histone deacetylase 2 (HDAC2). Since vitamin D may theoretically modulate HDAC2, this preliminary study aimed to evaluate the effect of vitamin D supplementation on HDAC2 levels in stable COPD patients at Jemursari Islamic Hospital, Surabaya. A one-group pre–post test experimental design without a control group was used. Five stable COPD patients meeting the inclusion criteria received 5000 IU of cholecalciferol daily for three months, with serum 25(OH)D₃ and HDAC2 measured before and after the intervention by ELISA and analysed using a paired t-test (p<0.05 considered significant). Supplementation significantly increased 25(OH)D₃ (7.63 ± 2.73 to 14.26 ± 2.43 ng/mL; p=0.023) and HDAC2 (1.50 ± 1.02 to 3.90 ± 1.39 ng/mL; p=0.006), whereas all pulmonary function parameters showed only an increasing trend without reaching statistical significance (all p>0.05). Vitamin D supplementation was associated with increased HDAC2, suggesting a potential molecular anti-inflammatory effect not yet accompanied by significant functional improvement. Given the very small sample (n=5) and the absence of a control group, these findings are hypothesis-generating and require confirmation in larger controlled trials before vitamin D can be considered as adjunctive COPD therapy.
The Effect of Vitamin-D Supplementation on HDAC2 Levels in Stable COPD Patients Adyan Donastin; Danny Irawan; Effendy; Rifky Dwi Aditya Iryawan; Nuzlan Nuari; Betta Mega Oktaviana; Devy Yahya; Akbar Reza Muhammad
Jurnal Ilmiah Kesehatan Vol 19 No 03 (2026): Jurnal Ilmiah Kesehatan (Journal of Health Science) 
Publisher : Universitas Nahdlatul Ulama Surabaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33086/jhs.v19i03.7169

Abstract

Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of global mortality, with persistent lung inflammation contributing to its progression. This inflammation is partially due to reduced levels of the Histone deacetylase 2 (HDAC2) protein. Research shows that Vitamin D can modulate HDAC2 levels and slow the advancement of COPD. This experimental study aimed to evaluate the effect of vitamin D supplementation on HDAC2 expression in stable COPD patients at Jemursari Islamic Hospital. Five randomly selected COPD patients received a daily dosage of 5000 IU of Vitamin D for three months. Serum levels of 25(OH) D and HDAC2 were measured before and after the intervention. The results showed a significant increase in both Vitamin D and HDAC2 levels, with a notable, though not statistically significant, improvement in lung function. The findings suggest that consistent Vitamin D supplementation can reduce inflammation by raising HDAC2 levels, potentially slowing lung damage in COPD patients. Therefore, Vitamin D treatment is beneficial in managing COPD by improving lung health and preventing disease progression.